共 147 条
[1]
Huxley R(2006)Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies BMJ 332 73-78
[2]
Barzi F(2008)The growing burden of diabetes mellitus in the US elderly population Arch Intern Med. 168 192-199
[3]
Woodward M(2003)Epidemiology of cardiovascular complications in type 2 diabetes mellitus Acta Diabetol 40 S358-S361
[4]
Sloan FA(2015)Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 38 140-149
[5]
Bethel MA(2009)Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association Diabetes Care 32 187-192
[6]
Ruiz D(2015)Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials Lancet Diabetes Endocrinol. 3 356-366
[7]
Shea AM(2015)Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes N Engl J Med 373 2117-2128
[8]
Feinglos MN(2015)Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes N Engl J Med 373 232-242
[9]
Meigs JB(2015)Lixisenatide in patients with type 2 diabetes and acute coronary syndrome N Engl J Med 373 2247-2257
[10]
Inzucchi SE(2013)Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus N Engl J Med 369 1317-1326